News | November 10, 2021
US govt places additional order of 1.4 million courses of molnupiravir
Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults
Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults
Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
Divi's Laboratories Limited has reported consolidated financial results for the period ended September 30, 2021.
The drug helps in managing cholesterol
It is the world’s first DNA-based Covid vaccine
The transplant procedure was completed in under two hours
The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity
The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day
Biocon Biologics and Viatris co-developed the products
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
Subscribe To Our Newsletter & Stay Updated
